UTHR
United Therapeutics Corporation · Healthcare · Biotechnology
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -6.0% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 86.02K | $43.82M | n/a | −2 |
| Q2 2026 | 157 | +4 | 27.98M | $15.17B | +8 | −5 |
| Q1 2026 | 157 | -1 | 29.64M | $17.54B | +5 | −7 |
| Q4 2025 | 157 | +1 | 32.29M | $15.72B | +2 | n/a |
| Q3 2025 | 21 | 0 | 20.11M | $8.43B | +1 | −2 |
| Q2 2025 | 19 | 0 | 20.17M | $5.79B | n/a | n/a |
| Q1 2025 | 16 | +1 | 10.14M | $3.12B | +1 | n/a |
| Q4 2024 | 15 | 0 | 10.52M | $3.71B | +1 | −1 |
| Q3 2024 | 14 | 0 | 8.99M | $3.22B | n/a | n/a |
| Q2 2024 | 14 | n/a | 8.17M | $2.60B | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.46M | -22.3% | $869.36M | 0.2% | ▼ Trim | 3 | SEC ↗ ×9 |
| 2 | State Street Global Advisors ✦ (被动) | 2.20M | n/a | $776.30M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 2.09M | -3.1% | $737.22M | 1.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 1.14M | +4.0% | $401.18M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | AQR Capital Management ✦ | 975.44K | +0.8% | $344.18M | 0.4% | ▲ Add | 3 | SEC ↗ ×6 |
| 6 | Arrowstreet Capital ✦ | 542.45K | -15.4% | $191.40M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 7 | Norges Bank ✦ (被动) | 430.12K | +1.5% | $151.76M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 397.88K | +15.5% | $140.39M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 9 | Bridgewater Associates ✦ | 107.73K | +74.5% | $38.01M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 10 | Gotham Asset Management ✦ | 61.18K | +17.5% | $21.59M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 43.29K | -16.0% | $15.27M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 12 | Millennium Management ✦ | 28.06K | +210.2% | $9.90M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 20.34K | 新增 | $7.18M | 0.0% | New | 1 | SEC ↗ ×2 |
| 14 | Fisher Asset Management ✦ | 16.34K | +159.1% | $5.77M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 1.77K | +3.0% | $625,585 | 0.0% | ▲ Add | 3 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Citadel Advisors | $7.18M | 0.0% |
已清仓
| Marshall Wace | $4.55M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 844 持有人, 41.22M 股份, $23.10B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer, Director · 315 股 · $176,612
Officer, Director · 320 股 · $178,280
Officer, Director · 520 股 · $290,537
Officer, Director · 586 股 · $322,311
Officer, Director · 1.13K 股 · $624,870
Officer, Director · 1.56K 股 · $860,883
Officer, Director · 1.26K 股 · $697,996
Officer, Director · 575 股 · $314,977
Officer, Director · 948 股 · $520,400
Officer, Director · 464 股 · $261,130
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论